These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 21546068)
1. Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies. Chen Y; Stirling RG; Paul E; Hore-Lacy F; Thompson BR; Douglass JA J Allergy Clin Immunol; 2011 Jun; 127(6):1414-7. PubMed ID: 21546068 [No Abstract] [Full Text] [Related]
2. Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors. Gregersen S; Aaløkken TM; Mynarek G; Fevang B; Holm AM; Ueland T; Aukrust P; Kongerud J; Johansen B; Frøland SS Ann Allergy Asthma Immunol; 2010 Jun; 104(6):503-10. PubMed ID: 20568383 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency. Wasserman RL; Church JA; Peter HH; Sleasman JW; Melamed I; Stein MR; Bichler J; Eur J Pharm Sci; 2009 Jun; 37(3-4):272-8. PubMed ID: 19491015 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy. Jolles S; Bernatowska E; de Gracia J; Borte M; Cristea V; Peter HH; Belohradsky BH; Wahn V; Neufang-Hüber J; Zenker O; Grimbacher B Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277 [TBL] [Abstract][Full Text] [Related]
6. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Aghamohammadi A; Allahverdi A; Abolhassani H; Moazzami K; Alizadeh H; Gharagozlou M; Kalantari N; Sajedi V; Shafiei A; Parvaneh N; Mohammadpour M; Karimi N; Sadaghiani MS; Rezaei N Respirology; 2010 Feb; 15(2):289-95. PubMed ID: 20051045 [TBL] [Abstract][Full Text] [Related]
7. Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. Bonagura VR; Marchlewski R; Cox A; Rosenthal DW J Allergy Clin Immunol; 2008 Jul; 122(1):210-2. PubMed ID: 18602574 [No Abstract] [Full Text] [Related]
8. Effects of intravenous immunoglobulin on clinical and immunological findings of patients with humoral immunodeficiency diseases. Ersoy F; Tezcan I; Sanal O Turk J Pediatr; 1992; 34(4):203-9. PubMed ID: 1306339 [TBL] [Abstract][Full Text] [Related]
9. A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency. Krivan G; Chernyshova L; Kostyuchenko L; Lange A; Nyul Z; Derfalvi B; Musial J; Bellon A; Kappler M; Sadoun A; Bernatowska E J Clin Immunol; 2017 Aug; 37(6):539-547. PubMed ID: 28711959 [TBL] [Abstract][Full Text] [Related]
10. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. Lucas M; Lee M; Lortan J; Lopez-Granados E; Misbah S; Chapel H J Allergy Clin Immunol; 2010 Jun; 125(6):1354-1360.e4. PubMed ID: 20471071 [TBL] [Abstract][Full Text] [Related]
11. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Aghamohammadi A; Farhoudi A; Nikzad M; Moin M; Pourpak Z; Rezaei N; Gharagozlou M; Movahedi M; Atarod L; Afshar AA; Bazargan N; Hosseinpoor AR Ann Allergy Asthma Immunol; 2004 Jan; 92(1):60-4. PubMed ID: 14756466 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency. Hagan JB; Fasano MB; Spector S; Wasserman RL; Melamed I; Rojavin MA; Zenker O; Orange JS J Clin Immunol; 2010 Sep; 30(5):734-45. PubMed ID: 20454851 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of immunoglobulin prophylaxis in humoral immunodeficiency. Björkander J; Bake B; Hanson LA Monogr Allergy; 1983; 18():156-9. PubMed ID: 6646135 [No Abstract] [Full Text] [Related]